HUTCHMED China Ltd - Asset Resilience Ratio

Latest as of June 2025: 70.66%

HUTCHMED China Ltd (HCM) has an Asset Resilience Ratio of 70.66% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

GBX1.25 Billion

Cash + Short-term Investments

Total Assets

GBX1.78 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2024)

This chart shows how HUTCHMED China Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down HUTCHMED China Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX1.25 Billion	70.66%
Total Liquid Assets	GBX1.25 Billion	70.66%

Asset Resilience Insights

Very High Liquidity: HUTCHMED China Ltd maintains exceptional liquid asset reserves at 70.66% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

HUTCHMED China Ltd Industry Peers by Asset Resilience Ratio

Compare HUTCHMED China Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Dongwha Pharm.Co.Ltd KO:000020	Drug Manufacturers - Specialty & Generic	1.72%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.46%
Yuhan Corp Preferred KO:000105	Drug Manufacturers - Specialty & Generic	0.99%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%
Kotra Industries Bhd KLSE:0002	Drug Manufacturers - Specialty & Generic	9.82%
Yuyu Pharma KO:000220	Drug Manufacturers - Specialty & Generic	1.74%
Ildong Holdings Co Ltd KO:000230	Drug Manufacturers - Specialty & Generic	1.57%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%

Annual Asset Resilience Ratio for HUTCHMED China Ltd (2006–2024)

The table below shows the annual Asset Resilience Ratio data for HUTCHMED China Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	53.54%	GBX682.15 Million	GBX1.27 Billion	+6.44pp
2023-12-31	47.10%	GBX602.75 Million	GBX1.28 Billion	+16.23pp
2022-12-31	30.86%	GBX317.72 Million	GBX1.03 Billion	-15.34pp
2021-12-31	46.20%	GBX634.16 Million	GBX1.37 Billion	+18.64pp
2020-12-31	27.56%	GBX199.55 Million	GBX724.12 Million	+6.37pp
2019-12-31	21.19%	GBX98.54 Million	GBX465.12 Million	-19.20pp
2018-12-31	40.39%	GBX214.91 Million	GBX532.12 Million	-5.27pp
2017-12-31	45.66%	GBX273.03 Million	GBX597.93 Million	+38.58pp
2016-12-31	7.09%	GBX24.27 Million	GBX342.44 Million	+6.74pp
2015-12-31	0.35%	GBX800.00K	GBX229.75 Million	-5.37pp
2014-12-31	5.72%	GBX12.53 Million	GBX218.94 Million	+3.09pp
2010-12-31	2.64%	GBX4.21 Million	GBX159.93 Million	-42.87pp
2006-12-31	45.51%	GBX60.54 Million	GBX133.04 Million	--

pp = percentage points

About HUTCHMED China Ltd

LSE:HCM UK Drug Manufacturers - Specialty & Generic

Market Cap

$23.00 Million

GBX189.05 Billion GBX

Market Cap Rank

#27531 Global

#477 in UK

Share Price

GBX220.00

Change (1 day)

+0.00%

52-Week Range

GBX193.00 - GBX286.00

All Time High

GBX624.00